| Literature DB >> 27823591 |
Nayara Cioffi Batagini1, David Hardy2, Daniel G Clair2, Lee Kirksey2.
Abstract
Clinical outcome reports document that from 30% to 60% of endovascular aneurysm repair procedures are performed outside of US Food and Drug Administration-approved Instruction for Use, or "off label." Endovascular aneurysm repair performed outside of Instruction for Use has a significantly higher rate of device failure, potentially requiring device reintervention and even planned or emergent explant. The Nellix device has the potential to reduce the rate of aneurysm device failure through its novel design. The objective of this article was to introduce the Nellix EndoVascular Aneurysm Sealing System and indications for use and describe the technique of implantation. We describe various modes of endovascular aneurysm repair failure and how the Nellix system can reduce these unplanned adverse outcomes. Additional clinical applications and theoretical shortcomings of endovascular aneurysm sealing devices are detailed.Entities:
Mesh:
Year: 2016 PMID: 27823591 DOI: 10.1053/j.semvascsurg.2016.04.001
Source DB: PubMed Journal: Semin Vasc Surg ISSN: 0895-7967 Impact factor: 1.000